NCT00512525View on ClinicalTrials.gov

Ghrelin Decreases Insulin Sensitivity

PHASE1CompletedINTERVENTIONAL

Enrollment

8

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

October 31, 2003

Study Completion Date

October 31, 2003

Conditions

Healthy Subjects

Interventions

DRUG

Ghrelin and saline (as placebo)

Intravenous infusion

All Listed Sponsors

lead

University of Aarhus

OTHER

NCT00512525 - Ghrelin Decreases Insulin Sensitivity | Biotech Hunter | Biotech Hunter